Immune checkpoints inhibitors and hyperglycemia: A Meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune checkpoints inhibitors and hyperglycemia: A Meta-analysis of randomized controlled trials

Published:2020-04 Issue: Volume:162 Page:108115
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Monami Matteo,Naletto Lara,Nreu Besmir,Dicembrini Ilaria,Sesti Giorgio,Mannucci Edoardo

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference19 articles.

1. Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies;Philips;Int Immunol,2015

2. Thyroid disorders induced by checkpoint inhibitors;Ferrari;Rev Endocrine Metabolic Disord,2018

3. Autoimmune diabetes associated with pembrolizumab: A review of published case reports;Cheema;World J Oncol,2018

4. Acquired Lipodystrophy Associated with Nivolumab in a Patient with Advanced Renal Cell Carcinoma;Falcao;J Clin Endocrinol Metabol,2019

5. A robust response to combination immune checkpoint inhibitor therapy in HPV-related small cell cancer: a case report;Ho;J ImmunoTher Cancer,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of diabetes mellitus in patients treated with immune checkpoint inhibitors (ICI) therapy – A comprehensive cancer center experience;Diabetes Research and Clinical Practice;2023-08

2. Hyperglycaemia following immune checkpoint inhibitor therapy—Incidence, aetiology and assessment;Diabetic Medicine;2023-02-06

3. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update;Endocrine Practice;2022-10

4. Type 1 diabetes with immune checkpoint inhibitors: A systematic analysis of clinical trials and a pharmacovigilance study of postmarketing data;International Immunopharmacology;2022-09

5. CANDIED: A Pan-Canadian Cohort of Immune Checkpoint Inhibitor-Induced Insulin-Dependent Diabetes Mellitus;Cancers;2021-12-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3